Large Cap High Growth Potential

Results

267

25 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

267 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	AXSM	US$212.74	-2.4%	103.0%	US$10.9b	US$282.32	15.5	57.0%	n/a	Pharmaceuticals & Biotech
	CRDO	US$249.89	20.7%	107.5%	US$46.6b	US$279.29	98.7	27.7%	n/a	Semiconductors
	GH	US$168.48	4.0%	210.7%	US$22.6b	US$194.29	19.1	64.0%	n/a	Healthcare
	MOD	US$195.60	-2.7%	43.6%	US$10.4b	US$310.29	72.0	51.3%	n/a	Capital Goods
	MDGL	US$510.04	9.1%	47.5%	US$11.8b	US$678.06	9.2	63.7%	n/a	Pharmaceuticals & Biotech
	LITE	US$890.17	24.7%	665.6%	US$69.3b	US$1,125.93	157.8	56.5%	n/a	Tech
	NVDA	US$223.96	11.6%	22.6%	US$5.4t	US$302.83	34.0	22.8%	0.4%	Semiconductors
	AMD	US$483.36	1.5%	179.8%	US$798.7b	US$608.23	122.0	38.3%	n/a	Semiconductors
	NU	US$13.84	-3.4%	12.5%	US$66.9b	US$17.98	5.3	20.2%	n/a	Banks
	BE	US$219.34	6.6%	496.0%	US$64.6b	US$273.51	263.7	42.5%	n/a	Capital Goods
	ARM	US$282.57	17.9%	104.0%	US$301.8b	US$286.79	289.1	38.5%	n/a	Semiconductors
	MRVL	US$218.72	16.6%	182.8%	US$191.5b	US$256.91	75.8	26.4%	0.1%	Semiconductors
	SMTC	US$139.42	18.3%	174.2%	US$13.0b	US$205.25	11.9	74.6%	n/a	Semiconductors
	FN	US$562.38	29.2%	63.5%	US$19.5b	US$732.44	47.9	22.3%	n/a	Tech
	AVGO	US$427.76	9.9%	40.3%	US$2.0t	US$527.88	69.4	33.7%	0.6%	Semiconductors
	CBRS	US$226.73	14.1%	n/a	US$51.4b	US$292.00	525.5	73.7%	n/a	Semiconductors
	RDDT	US$161.70	14.9%	-24.9%	US$31.1b	US$216.35	35.7	24.1%	n/a	Media
	AXON	US$571.01	8.2%	-32.2%	US$42.1b	US$691.83	230.9	25.4%	n/a	Capital Goods
	LSCC	US$130.03	4.6%	111.4%	US$18.5b	US$164.92	508.4	69.9%	n/a	Semiconductors
	APP	US$346.80	-12.4%	-23.9%	US$116.1b	US$560.83	26.3	20.7%	n/a	Media
	ALAB	US$334.17	7.4%	86.4%	US$58.0b	US$383.24	156.9	33.2%	n/a	Semiconductors
	INSM	US$131.10	33.0%	19.7%	US$28.6b	US$200.50	25.2	66.5%	n/a	Pharmaceuticals & Biotech
	MTSI	US$310.82	23.6%	157.0%	US$23.7b	US$401.54	98.5	35.6%	n/a	Semiconductors
	PRAX New	US$360.76	17.2%	685.3%	US$10.1b	US$621.63	7.5	71.0%	n/a	Pharmaceuticals & Biotech

Page 1 of 8